ProF-001_Phase IIa

Condition:   Vulvovaginal Candidiasis (VVC) Interventions:   Drug: Candiplus;   Drug: Clotrimazole Sponsor:   ProFem GmbH Recruiting - verified April 2017

Source: ClinicalTrials.gov - March 13, 2017 Category: Research Source Type: clinical trials